Animal Health Pharmaceuticals

The Veterinary Oncology Market Size Worth will be wroth $.5B Million by 2027.Pet cancer therapeutics for lymphoma market alone is expected to expand at 19.1% CAGR between 2021 and 2029. Lymphoma is the most common pet cancer, especially in dogs. Until recently there had been hardly any medicine available for dog cancer treatment.

The global companion animal cancer drug market is a moderately competitive market. Zoetis, Inc, Elanco (Eli Lily), Merck & Co., Inc., and Merial (Boehringer Ingelheim) are the major player with the maximum revenue share to the market.

Historically expansion of the business through mergers, acquisitions, collaborations, and alliances has been brisk.